Procept Biorobotics share price today

(PRCT)

Procept Biorobotics share price is $81.17 & ₹6,897.50 as on 21 Dec 2024, 2.30 'hrs' IST

$81.17

▲

0.39

(0.48%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Procept Biorobotics share price in Dollar and Rupees. Guide to invest in Procept Biorobotics from India. Also see the sentimental analysis on Indian investors investing in Procept Biorobotics. Get details on the Indian mutual funds that are investing in Procept Biorobotics. Get Analyst recommendations and forecasts along with all the Procept Biorobotics's financials.

Procept Biorobotics share price movements

Today's Low: $79.86
Today's High: $82.28
$81.17
1.61%
Downside
Day's Volatility :2.94%
Upside
1.34%
52 Weeks Low: $39.48
52 Weeks High: $103.81
$81.17
51.36%
Downside
52 Weeks Volatility :61.97%
Upside
21.81%

Procept Biorobotics Returns

Period	Procept Biorobotics	Sector (Health Care)	Index (Russel 2000)
3 Months	1.17%	-11.1%	0.0%
6 Months	38.35%	-6.0%	0.0%
1 Year	90.14%	2.7%	0.0%
3 Years	200.18%	0.6%	-19.7%

Procept Biorobotics Key Statistics

in dollars & INR

Previous Close	$80.78
Open	$79.41
Today's High	$82.275
Today's Low	$79.86
Market Capitalization	$4.4B
Today's Volume	$1.1M
52 Week High	$103.8099
52 Week Low	$39.48
Revenue TTM	$199.8M
EBITDA	$-101.4M
Earnings Per Share (EPS)	$-1.95
Profit Margin	-50.07%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.02%

How to invest in Procept Biorobotics from India?

It is very easy for Indian residents to invest directly in Procept Biorobotics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Procept Biorobotics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Procept Biorobotics or PRCT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Procept Biorobotics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Procept Biorobotics shares which would translate to 0.010 fractional shares of Procept Biorobotics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Procept Biorobotics, in just a few clicks!

Returns in Procept Biorobotics for Indian investors in Rupees

Investment Value

₹1,00,000

Procept Biorobotics investment value today

Current value as on today

₹1,92,334

Returns

₹92,334

(+92.33%)

Returns from Procept Biorobotics Stock

₹90,138 (+90.14%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Procept Biorobotics

-36%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Procept Biorobotics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -36% less investors are searching Procept Biorobotics in the last 30 days versus the previous period.

Global Institutional Holdings in Procept Biorobotics

FMR Inc
13.48%
Vanguard Group Inc
8.95%
BlackRock Inc
6.44%
AllianceBernstein L.P.
2.84%
Loomis, Sayles & Company LP
2.30%
State Street Corp
2.18%

Analyst Recommendation on Procept Biorobotics

Buy

86%Buy

13%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Procept Biorobotics(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Procept Biorobotics

What analysts predicted

Upside of 26.59%

Current:

$81.17

Target:

$102.75

Insights on Procept Biorobotics

Price Movement
In the last 1 year, PRCT stock has moved up by 90.8%
Increasing Revenue
Revenue is up for the last 18 quarters, 1.19M → 58.37M (in $), with an average increase of 19.0% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -27.50M → -20.97M (in $), with an average increase of 9.8% per quarter

Procept Biorobotics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$6.2M	-
Net Income	$-42.7M	-
Net Profit Margin	-691.41%	-

	FY20	Y/Y Change
Revenue	$7.7M	↑ 25.09%
Net Income	$-58.3M	↑ 36.58%
Net Profit Margin	-754.89%	↓ 63.48%

	FY21	Y/Y Change
Revenue	$34.5M	↑ 346.72%
Net Income	$-62.4M	↑ 7.09%
Net Profit Margin	-180.96%	↑ 573.93%

	FY22	Y/Y Change
Revenue	$75.0M	↑ 117.6%
Net Income	$-93.6M	↑ 50.01%
Net Profit Margin	-124.76%	↑ 56.2%

	FY23	Y/Y Change
Revenue	$136.2M	↑ 81.55%
Net Income	$-105.9M	↑ 13.16%
Net Profit Margin	-77.76%	↑ 47.0%

	Q2 FY23	Q/Q Change
Revenue	$33.1M	↑ 35.65%
Net Income	$-25.3M	↓ 8.73%
Net Profit Margin	-76.38%	↑ 37.15%

	Q3 FY23	Q/Q Change
Revenue	$35.1M	↑ 6.04%
Net Income	$-24.6M	↓ 2.62%
Net Profit Margin	-70.14%	↑ 6.24%

	Q4 FY23	Q/Q Change
Revenue	$43.6M	↑ 24.16%
Net Income	$-27.5M	↑ 11.7%
Net Profit Margin	-63.11%	↑ 7.03%

	Q1 FY24	Q/Q Change
Revenue	$44.5M	↑ 2.2%
Net Income	$-26.0M	↓ 5.62%
Net Profit Margin	-58.28%	↑ 4.83%

	Q2 FY24	Q/Q Change
Revenue	$53.4M	↑ 19.79%
Net Income	$-25.6M	↓ 1.28%
Net Profit Margin	-48.03%	↑ 10.25%

	Q3 FY24	Q/Q Change
Revenue	$58.4M	↑ 9.4%
Net Income	$-21.0M	↓ 18.15%
Net Profit Margin	-35.93%	↑ 12.1%

	FY19	Y/Y Change
Profit	$-1.9M	-

	FY20	Y/Y Change
Profit	$-1.3M	↓ 33.42%

	FY21	Y/Y Change
Profit	$15.9M	↓ 1364.14%

	FY22	Y/Y Change
Profit	$37.1M	↑ 133.75%

	FY23	Y/Y Change
Profit	$71.0M	↑ 91.58%

	Q2 FY23	Q/Q Change
Profit	$18.4M	↑ 47.54%

	Q3 FY23	Q/Q Change
Profit	$18.9M	↑ 2.41%

	Q4 FY23	Q/Q Change
Profit	$19.9M	↑ 5.63%

	Q1 FY24	Q/Q Change
Profit	$25.0M	↑ 25.57%

	Q2 FY24	Q/Q Change
Profit	$30.2M	↑ 20.69%

	Q3 FY24	Q/Q Change
Profit	$36.9M	↑ 22.17%

	FY19	Y/Y Change
Operating Cash Flow	$-43.8M	-
Investing Cash Flow	$43.2M	-
Financing Cash Flow	$26.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 10.33%
Investing Cash Flow	$-233.0K	↓ 100.54%
Financing Cash Flow	$106.8M	↑ 302.5%

	FY21	Y/Y Change
Operating Cash Flow	$-57.3M	↑ 18.6%
Investing Cash Flow	$-592.0K	↑ 154.08%
Financing Cash Flow	$262.1M	↑ 145.49%

	FY22	Y/Y Change
Operating Cash Flow	$-80.4M	↑ 40.2%
Investing Cash Flow	$-2.7M	↑ 348.14%
Financing Cash Flow	$3.6M	↓ 98.62%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-28.3M	↓ 21.12%
Investing Cash Flow	$-5.4M	↑ 0.62%
Financing Cash Flow	$2.4M	↑ 539.47%

Procept Biorobotics Technicals Summary

Sell

Neutral

Buy

Procept Biorobotics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Procept Biorobotics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Procept Biorobotics	-13.28%	38.35%	90.14%	200.18%	93.54%
Stryker Corporation	-6.55%	7.53%	21.91%	35.92%	72.32%
Boston Scientific Corp.	-2.79%	15.96%	58.87%	108.22%	96.31%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.93%	-41.81%	-4.82%
Abbott Laboratories	-2.58%	8.48%	4.58%	-17.91%	30.88%
Medtronic Plc	-4.38%	-0.01%	-1.54%	-21.25%	-28.78%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Procept Biorobotics	53.06	NA	NA	-1.75	-0.37	-0.17	NA	4.63
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Procept Biorobotics	Buy	$4.4B	93.54%	53.06	-50.07%
Stryker Corporation	Buy	$136.1B	72.32%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.31%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-4.82%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.88%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.78%	24.46	12.06%

About Procept Biorobotics

based in silicon valley, procept biorobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. with an initial focus on benign prostatic hyperplasia (bph), the company’s first product, the aquabeam system delivering aquablation therapy, is the world’s first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat bph. aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.

Organization	Procept Biorobotics
Employees	626
CEO	Dr. Reza Zadno Ph.D.
Industry	Healthcare

Management People of Procept Biorobotics

Name	Title
Dr. Reza Zadno Ph.D.	President, CEO & Director
Mr. Kevin Waters	Executive VP & CFO
Ms. Alaleh Nouri	EVP, Chief Legal Officer & Corporate Secretary
Mr. Hisham Shiblaq	Executive VP & Chief Commercial Officer
Mr. Mohan F. Sancheti	Senior Vice President of Operations
Mr. Barry Templin	Executive VP of Technology & Clinical Development
Mr. Matthew James Bacso C.F.A.	Vice President of Investor Relations
Ms. Stacey L. Porter	Chief People Officer
Mr. Bijesh Chandran	Senior Vice President of Regulatory Affairs & Quality Assurance

Important FAQs about investing in Procept Biorobotics from India :

What is Procept Biorobotics share price today?

Procept Biorobotics share price today stands at $81.17, Open: $79.41 ; Previous Close: $80.78 ; High: $82.28 ; Low: $79.86 ; 52 Week High: $103.81 ; 52 Week Low: $39.48. The stock opens at $79.41, after a previous close of $80.78. The stock reached a daily high of $82.28 and a low of $79.86, with a 52-week high of $103.81 and a 52-week low of $39.48.

Can Indians buy Procept Biorobotics shares?

Yes, Indians can invest in the Procept Biorobotics (PRCT) from India.

With INDmoney, you can buy Procept Biorobotics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Procept Biorobotics at zero transaction cost.

How can I buy Procept Biorobotics shares from India?

It is very easy to buy Procept Biorobotics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Procept Biorobotics be purchased?

Yes, you can buy fractional shares of Procept Biorobotics with INDmoney app.

What are the documents required to start investing in Procept Biorobotics stocks?

To start investing in Procept Biorobotics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.